Virtual reality and glowing dye could make lung cancer surgery safer

NCT ID NCT06638125

Not yet recruiting Disease control Sponsor: St. Joseph's Healthcare Hamilton Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new way to perform lung cancer surgery using 3D virtual reality models and a special dye that makes lung segments glow during surgery. The goal is to help surgeons remove only the diseased part of the lung more accurately. About 89 adults with early-stage non-small cell lung cancer will take part. The study will check if the technique is safe, feasible, and improves surgical success.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Indocyanine green (ICG) dye
What this could lead to: If successful, this could make lung-sparing surgery more precise and successful for early-stage lung cancer patients.
What could go wrong: This is an early-phase trial with only 89 participants, so results may not apply broadly. The technique is new and may not improve outcomes or could have unforeseen risks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NON-SMALL CELL LUNG CANCER

Contacts and locations

Locations

St. Joseph's Healthcare Hamilton

Hamilton, Ontario, L8N 4A6, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.